Urotensin II (UII), a vasoactive peptide with structural similarity to somatostatin, is the most potent vasoconstrictor known in systemic resistance vessels and has multiple biological effects related to a variety of human diseases. Numerous studies have found that UII and its receptor (UT) play an important role in the pathogenesis of portal hypertension. This paper reviews the recent advances in understanding the role of the UII/UT system in the pathogenesis of portal hypertension.
语种：
外文
第一作者：
第一作者机构：[1]首都医科大学宣武医院普外科北京市100053
通讯作者：
通讯机构：[2]首都医科大学附属北京友谊医院普外科,北京市宣武区永安路 95号
推荐引用方式(GB/T 7714)：
刘殿刚,王宇.Advances in understanding the role of the UII/UT system in the pathogenesis of portal hypertension[J].World Chinese Journal of Digestology.2010,18(31):
APA：
刘殿刚&王宇.(2010).Advances in understanding the role of the UII/UT system in the pathogenesis of portal hypertension.World Chinese Journal of Digestology,18,(31)
MLA：
刘殿刚,et al."Advances in understanding the role of the UII/UT system in the pathogenesis of portal hypertension".World Chinese Journal of Digestology 18..31(2010)
